63
Views
25
CrossRef citations to date
0
Altmetric
Research Article

G-CSF Administered in Time-sequenced Setting During Remission Induction and Consolidation Therapy of Adult Acute Lymphoblastic Leukemia has Beneficial Influence on Early Recovery and Possibly Improves Long-term Outcome: A Randomized Multicenter Study

, , , , , , , , , , , , , , , , , & show all
Pages 315-325 | Published online: 01 Jul 2009

  • Larson, R.A., Dodge, R.K., Linker, C.A., Stone, R.M., Powell, B.L., Lee, E.J., Schulman, P., Davey, F.R., Frankel, S.R., Bloomfield, C.D., George, S.L. and Schiffer, C.A. (1998) "A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111", Blood 92, 1556-1564.
  • Pui, C.H., Boyett, J.M., Hughes, W.T., Rivera, G.K., Hancock, M.L., Sandlund, J.T., Synold T., Relling, M.V., Ribeiro, R.C., Crist, W.M. and Evans, W.E. (1997) "Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia", N. Engl. J. Med. 336, 1781-1787.
  • Ottmann, O.G., Hoelzer, D., Gracien, E., Ganser, A., Kelly, K., Reutzel, R., Lipp, T., Busch, F.W., Schwonzen, M., Heil, G., et al., (1995) "Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial", Blood 86, 444-450.
  • Geissler, K., Koller, E., Hubmann, E., Niederwieser, D., Hinterberger, W., Geissler, D., Kyrle, P., Knobl, P., Pabinger, I., Thalhammer, R., Schwarzinger, I., Mannhalter, C., Jaeger, U.,Heinz, R., Linkesch, W. and Lechner, K. (1997) "Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia-a randomized phase-III study", Blood 90, 590-596.
  • Alvarado Ibarra, M.L., Borbolla Escoboza, J.R., Lopez-Hernandez, M.A., Gonzalez-Avante, C.M., Flores Chapa, J.D., Trueba Christy, E. and Anaya Cuellar, I. (1999) "Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF", Rev. Invest. Clin. 51, 77-80.
  • martino, R., Bellido, M., Brunet, S., Altes, A., Sureda, A., Guardia, R., Aventin, A., Nomdedeu, J.F., Domingo-Albos, A. and Sierra, J. (1999) "Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial", Haematologica 84, 505-510.
  • Dibenedetto, S.P., Ragusa, R., Ippolito, A.M., Lo Nigro, L., Di Cataldo, A., D'Amico, S. and Miraglia, V. (1995) "Assessment of the value of treatment with granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia: a randomized clinical trial", Eur. J. Haematol. 55, 93-96.
  • Hartmann, L.C., Tschetter, L.K., Habermann, T.M., Ebbert, L.P., Johnson, P.S., Mailliard, J.A., Levitt, R., Suman, V.J., Witzig, T.E., Wieand, H.S., Miller, L.L. and Moertel, C.G. (1997) "Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia", N. Engl. J. Med. 336, 1776-1780.
  • Clarke, v., Dunstan, F.D. and Webb, D.K. (1999) "Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia", Med. Pediatr. Oncol. 32, 331-335.
  • Takeyama, H., Yamada, H., Emi, N., Saito, H., Takeshita, A., Ohno, R., Yoshida, H., Naoe, T., Kageyama, S., Shirakawa, S., et al., (1995) "Efficacy of early administration of G-CSF after intensive chemotherapy in acute leukemia: a randomized controlled trial. Tokai infection study group on hematological disorders", Rinsho Ketsueki 36, 1257-1265.
  • Calderwood, S., Romeyer, F., Blanchette, V., Chan, H., Doyle, J., Greenberg, M., Lorenzana, A., malkin, D., Saunders, F., Weitzman, S., et al., (1994) "Concurrent RhGM-CSF does not offset myelosuppression from intensive chemotherapy: randomized placebo-controlled study in childhood acute lymphoblastic leukemia", Am. J. Hematol. 47, 27-32.
  • Toner, G.C., Shapiro, J.D., Laidlaw, C.R., Rischin, D., Millward, M.J., Wolf, M., Januszewicz, H., Mitchell, S.V., Curran, A.C., Matthews, J.P. and Bishop, J.F. (1998) "Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, corssover comparison", J. Clin. Oncol. 16, 3874-3879.
  • Holowiecki, J., Cedrych, I., Krzemien, S., Rudzka, W., Holowiecka, B., Jagoda, K., Krawczyk, M., Hellmann, A., Maj, S., Konopka, L., Dmosznska, A., Drykowski, E., Robak, T., Kuratowska, Z. and Skotnicki, A. (1996) "GM-CSF in addition to chemotherapy of ALL for kinetics based protection of stem cells and stimulation of haemopoiesis. A randomized study", NATO ASI Series (Springer, Berlin) Vol. H 94, pp 429-440.
  • Aglieta, M., Piacibello, W., Sanavio, F., Stacchini, A., Apra, F., Schena, M., Mossetti, C., Carnino, F., Caligaris-Cappio, F. and Gavosto, F. (1989) "Kinetics of human hematopoietic cells after in vivo administration of granulocyte macrophage colony stimulating factor", J. Clin. Invest. 83, 551-557.
  • Kantarjian, H.M., Estey, E.H., O'Brien, S., Anaissie, E., Beran, M., Rios, M.B., Keating, M.J. and Gutterman, J. (1992) "Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia", Blood 79, 876-881.
  • ASCO Ad Hoc Colony-Stimulating Factor Guidelines Expert Panel(1994) "American society of clinical oncology: recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines", J. Clin. Oncol. 12, 2471-2508.
  • Meropol, N.J., Miller, L.L., Korn, E.L., Braitman, L.E., MacDermott, M.L. and Schuchter, L.M. (1992) "Severe myelo-supperession resulting from concurrent administration of granulocyte colony factor and cytotoxic chemotherapy", J. Natl. Cancer Inst. 84, 1201-1203.
  • Scherrer, R., Geissler, K., Kyrle, P.A., Gisslinger, H., Jager, U., Bettelheim, P., laczika, K., Locker, G., Scholten, C., Sillaber, C., et al., (1993) "Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL)", Ann. Hematol. 66, 283-289.
  • De Wit, R., Verweij, J., Bontenbal, M., Kruit, W.H.J., Seynaeve, C., Schmitz, P.I.M. and Stoter, G. (1996) "Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support", J. Natl, Cancer Inst. 88, 1393-1398.
  • Durrant, I.J., Prentice, H.G. and Richards, S.M. (1997) "Intensification of treatment for adults with acute lymphoblastic leukemia: results of UK Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukemia in Adults", Br. J. Haematol 99. 84-92.
  • Dekker, A. W., van't Veer, M. B., Sizoo W., Haak, H. L., van der Lelie, J., Ossenkoppele, G., Huijgens, P.C., Schouten H. C., Sonneveld, P., Willemze R., Verdonck, L.F., van Putten, W.L., and Lowenberg, B. (1997) "Intensive Postremission chemotherapy without maintenance tehrapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group", J. Clin. Oncol. 15, 476-482.
  • Mandelli, F., Annino, L. and Rotoli, B. (1996) "The GIMEMA ALL 0183 trial: analysis of 10-year follow-up GIMEMA Cooperative Group, Italy", Br. J. Haematol. 92, 665-672.
  • Larson, R. A., Dodge, R. K., Burns, C.P., Lee, E.J., Stone, R. M., Schulman, P., Duggan, D., Davey F.R., Sobol, R.E., Frankel, S.R., et al., (1995) "A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and Leukemia group B study 8811", Blood 85, 2025-2037.
  • Fiere, D., Lepage, E., Sebban, C., Boucheix, C., Gisselbrecht, C., Vernant, J.P., Varet, B., Broustet, A., Cahn, J.Y., Rigal-Huguet, F., et al., (1993) "Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for adults acute lymphoblastic leukemia", J. Clin. Oncol. 11, 1990-2001.
  • Bassan, R., Lerede, T., Di Bona, E., Rossi, G., Pogliani, E., Rambaldi, A., Buelli, M., Viero, P., Rodeghiero, F., Izzi, T., Corneo, G. and Barbui, T. (1997) "Granulocyte colony-stimulating factor (G-CSF, filgrastim) after or during an intensive remission induction therapy for adult acute lymphoblastic leukemia: effects, role of patient pretreatment characteristics, and costs", Leuk. Lymph. 26, 153-161.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.